Advertisement
Molecular markers could potentially predict major adverse side effects
Findings in both health and MI highlight need for sex-specific pharmacotherapy research
High efficacy reported for vaccine candidates in interim analyses
Research consortium launches multisite investigations of the impact of aberrant immunity
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Preclinical studies point to antitumor activity of the ERM inhibitor NSC668394
After adjusting for comorbidities, melatonin usage was associated with reduced risk
$3.8M NIH grant fuels effort to develop a multimodal and multivariate model
Sones award honoree advancing knowledge in leukemia, bone marrow failure syndromes
Funding expands work by consortium led by Cleveland Clinic Lerner Research Institute and CWRU
Mutational pattern in MDS is not random, study finds
Advertisement
Advertisement